Ensuring the Success of Phage Therapy: Identifying and Characterizing Antiphage Defence in the Human and Aquacultural Pathogen Vibrio parahaemolyticus

确保噬菌体治疗的成功：识别和表征人类和水产养殖病原体副溶血弧菌中的抗噬菌体防御

• 批准号: 472056
• 负责人: Getz Landon J
• 金额: $ 9.83万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Fellowship Programs
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-10-01 至 2025-10-01
• 项目状态: 未结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=472056&lang=en
• 关键词: Antiphage Defence; Novel Therapeutics; Pandemic And Emerging Pathogens; Phage Therapy; Seafood-Borne Diarrhea; Vibrio Parahaemolyticus

Antibiotic resistance is on the rise, generating "superbugs" or infections which cannot be treated through traditional antibiotic therapy. As such, researchers are pursuing alternative treatments. One such alternative treatment is phage therapy, the use o

抗生素耐药性正在上升，产生了无法通过传统抗生素疗法治疗的“超级细菌”或感染。因此，研究人员正在寻求替代治疗。这样的替代治疗方法是噬菌体治疗，使用O